Company intelligence
EVA pharma
Empower the fight for health and well being as a human right
About EVA pharma
EVA Pharma is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products. With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies. Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand. EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 60 countries worldwide.
Verified activity
Signals from EVA pharma
11 published signals
Presence & Recognition
EVA Pharma hosted Yalla Summer to provide employees with a summer break to enjoy the summer, recharge, and continue making an impact.
Reported by EVA pharma
Presence & Recognition
EVA Pharma participated in Pharmaconex for three days, meeting international partners and suppliers to collaborate and ensure manufacturing standards for global patients.
Reported by EVA pharma
People
EVA Pharma is seeking a Vaccine Quality Assurance Section Head to join the dynamic team.
Reported by EVA pharma
Presence & Recognition
EVA pharma will meet with pharmaceutical leaders and international suppliers for Day 3 at Hall 3 - Booth 10.
Reported by EVA pharma
Presence & Recognition
EVA pharma met with pharmaceutical leaders and international suppliers from across the globe during the second day of Pharmaconex to collaborate, secure raw materials, and unlock new markets.
Reported by EVA pharma
Presence & Recognition
EVA pharma expanded global partnerships during the second day of Pharmaconex to reach more patients worldwide.
Reported by EVA pharma
Presence & Recognition
EVA pharma participated in Pharmaconex Day 1, bringing together industry pioneers to address regional manufacturing capabilities and future-ready healthcare solutions.
Reported by EVA pharma
Presence & Recognition
EVA pharma welcomed Dr. Ali Al-Ghamrawy, Chairman of the Egyptian Drug Authority (EDA), to the EVA Pharma booth during Day 1 of Pharmaconex 2026.
Reported by EVA pharma
Presence & Recognition
EVA pharma participated in Day 1 of Pharmaconex, connecting with industry leaders, partners, and innovators across the pharmaceutical manufacturing ecosystem.
Reported by EVA pharma
People
EVA Pharma is seeking a Software Development Tech Lead to join the team with a team of 10–14 full-stack engineers.
Reported by EVA pharma
Presence & Recognition
EVA Pharma hosted the Research & Development annual meeting to reconnect, reflect, and fuel up for the next wave of scientific innovation.
Reported by EVA pharma